Completed

Insulinsensitivität Des Menschlichen Zentralnervensystems: Kernspintomographische Untersuchung Mit Intranasaler Gabe Von Insulin

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Human Insulin

+ Placebo

Drug
Who is being recruted

Body Weight+9

+ Endocrine System Diseases

+ Metabolic Diseases

From 18 to 60 Years
+17 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Basic Science Study

Placebo-Controlled
Interventional
Study Start: February 2013
See protocol details

Summary

Principal SponsorUniversity Hospital Tuebingen
Last updated: December 3, 2015
Sourced from a government-validated database.Claim as a partner

Study start date: February 1, 2013

Actual date on which the first participant was enrolled.

The purpose of the study is to investigate whether insulin sensitivity and insulin resistance of the human brain is comparable in all insulin sensitive parts of the brain and whether correlates to other phenotypic information (i.e. whole body insulin sensitivity, BMI, age) of the study participants.

NCT01797601
Principal SponsorUniversity Hospital Tuebingen
Last updated: December 3, 2015
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

48 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Basic Science Study

Basic science studies help researchers understand how the body works or how a disease develops. They don't test treatments, but they build the foundation for future therapies.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 60 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Body WeightEndocrine System DiseasesMetabolic DiseasesNutrition DisordersNutritional and Metabolic DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsOvernutritionGlucose Metabolism DisordersOverweightDiabetes MellitusObesity

Criteria

3 inclusion criteria required to participate
Normal routine blood works
for women: negative pregnancy test
healthy
14 exclusion criteria prevent from participating
Artificial heart valves
Braces
Ear disease or an increased sensitivity to loud noises
Implanted magnetic metal parts (screws, ...)
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

50% chance of being blinded to the placebo group

Treatment Groups

Group I

Active Comparator
Nasal spray

Group II

Placebo
Nasal spray

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

University of Tuebingen

Tübingen, GermanyOpen University of Tuebingen in Google Maps
CompletedOne Study Center